The presence of a healthy epithelium can moderate the contraction of the underlying airway smooth muscle. This is, in part, because epithelial cells generate inhibitory messages, whether diffusible substances, electrophysiological signals, or both. The epithelium-dependent inhibitory effect can be tonic (basal), synergistic, or evoked. Rather than a unique epithelium-derived relaxing factor (EpDRF), several known endogenous bronchoactive mediators, including nitric oxide and prostaglandin E 2, contribute. The early concept that EpDRF diffuses all the way through the subepithelial layers to directly relax the airway smooth muscle appears unlikely. It is more plausible that the epithelial cells release true messenger molecules, which alter the production of endogenous substances (nitric oxide and/or metabolites of arachidonic acid) by the subepithelial layers. These substances then diffuse to the airway smooth muscle cells, conveying epithelium dependency.
MORE THAN A QUARTER OF A CENTURY ago, fueled by the explosion of knowledge concerning the role of the endothelium in controlling the tone of vascular smooth muscle, we embarked on a simple-minded expedition to test Mother Nature for a lack of imagination. Hence, we examined whether gentle removal of the epithelium in airways affected the contractile responsiveness of the underlying bronchial smooth muscle, and we discovered that it did (39, 41). Other investigators concurred, and, for a while, the field of epithelium-dependent control of airway tone was funded and, thus, blooming. The concept of epithelium-dependent control of smooth muscle tone has been extended to other hollow structures of the body, such as the urinary and reproductive systems (9, 100, 103, 104, 113) . The work in the airways performed in the 1980s has been repeatedly reviewed, and the reader is referred to those accounts for detailed information about those early experimental years (15, 42, 84, 109, (115) (116) (117) . As often occurs in science, interest rapidly fades if no spectacular discoveries are made. This seems to have been the case for epithelium-dependent bronchomotor control, as no novel gaseous transmitter [e.g., nitric oxide (NO)] or ugly peptide (e.g., endothelin-1) emerged. Although experimental work continued steadily, only occasional recognition was given to the field over the years (1, 7, 43, 86, 100) . The present review will attempt, in a nonexhaustive manner, to revisit the concept of epithelium-dependent control of airway smooth muscle, in the light of those studies published since 1990 of which the author is aware, and will try to determine whether some of the questions raised by the early work on epitheliumderived relaxing factor (EpDRF) have been answered in a definitive manner.
Does the Epithelium Inhibit the Tone of the Underlying Airway Smooth Muscle?
The concept withstood the test of time. Indeed, the observation that removal of the epithelium favors contraction/constriction of the airways has continued to be reported over the years. This is the case in airways of several species and, most importantly, in humans (Table 1) . Why the bovine trachea appears to be an exception (101) may seem mysterious, but in those studies the authors removed not only the epithelium, but also the submucosal layers.
Basal and/or Stimulated Release of EpDRF?
In the initial experiments performed in isolated canine bronchi, the epithelium was removed by gentle rubbing of the luminal surface ( Fig. 1) , without apparent morphological damage to the underlying subepithelial layers in general and the bronchial smooth muscle in particular (39, 49). This approach was, and still is, suitable to determine in vitro the consequences of removal of the epithelium per se on the responsiveness of airways to bronchoconstrictor or bronchodilator stimuli. As regards the former, the removal of the epithelium caused parallel leftward shifts, without changes in the maximal responses, of the concentration-response curves to acetylcholine, histamine, and 5-hydroxytryptamine, implying that the presence of the epithelial layer exerts a tonic restraint that reduces the responsiveness of airway smooth muscle without affecting its ability to contract (84) . This situation is reminiscent of the early days of endothelial research, when similar shifts in the concentration-response curve to vasoconstrictor agonists were attributed to "basal release" of endothelium-derived relaxing factors (78) . Obviously, we have to keep in mind that such shifts in concentration-contraction curves could also be explained if the epithelium acts as a diffusion barrier or a metabolic sink for the bronchoconstrictor substances (28, 56, 84, 88, 94) . Of course, the latter caveat does not apply if the presence of the epithelium potentiates responses to bronchodilator agents, as in the case of ␤-adrenoceptor agonists (84, 85) , NO donors (109) , and natriuretic peptides (79) . In certain instances, the interpretation of experiments investigating the role of the epithelium in airway responsiveness is further complicated by the fact that epithelial cells also can generate bronchoconstrictor substances (13, 26, 50, 53-55, 99, 107, 114, 118, 119, 121) .
In addition, "true" epithelium-dependent relaxations of precontracted airway smooth muscles had been reported with ␤ 2 -adrenoceptor agonists, arachidonic acid, the Ca 2ϩ ionophore A23187, the Ca 2ϩ channel blocker verapamil, and methylxanthines (84) . This list has been extended to a number of other substances (Table 2) . It is almost refreshing to see that certain bronchodilator agents do not invoke the help of the epithelium (10, 82, 102)! Despite our perception of the role of epithelial dysfunction in airway hyperresponsiveness, the description and discussion of novel bronchodilator mechanisms are often restricted to airway smooth muscle and ignore the potential modulation by the epithelium (8, 83). Alternatively, the potential impact of a suspected villain on epithelium-dependent modulation of airway tone has not always been considered, although the epithelial cell layer is often the first to be addressed. For example, the pattern-recognition receptor for advanced glycation end products (originally discovered in the lungs) and its ligands appear to play a major role in epithelial damage and bronchial hyperresponsiveness (11), but we do not, or at least the author does not, know whether they modulate epithelium-dependent responses. Similarly, matrix metalloproteinase 7, suspected to play a major role in endothelial dysfunction (74, 75), contributes to the hyperresponsiveness of asthma (57), but we do not know whether this involves abnormal release of epitheliumderived bronchoactive mediators.
Besides contributing to the response to certain bronchodilator substances, epithelium-dependent relaxations occur in response to cooling, hypoxia, and changes in osmolarity (84 the demonstration in canine bronchi that the potentiating effect of epithelium removal on contractions to acetylcholine, histamine, and 5-hydroxytryptamine diminishes, while the effect of its presence on the relaxation to ␤-adrenoceptor agonists becomes more pronounced, with narrowing of the bronchi (84, 109, 110) . Similarly, we should keep in mind that the relative impact of EpDRF can be modulated by local physiological variables (24 -26, 59) or by inflammatory mediators such as LPS (21) or major basic protein of eosinophils (40). In particular, since day one of EpDRF research, the conviction that the epithelial disruption that accompanies asthma, with the resulting inflammation and loss of epithelium-dependent relaxation, must be a major player in the airway hyperresponsiveness characteristic of the disease has been entrenched and never challenged (3, 7, 11, 16, 43, 62, 63, 73, 84 -86) .
Does EpDRF Exist?
The epithelium dependency of bronchodilator responses can only be accepted as foolproof evidence for the release of an EpDRF if no relaxation is observed in the absence of the epithelial layer or if the latter reverses the response to contraction (2, 43, 105) . If the presence of the epithelium only po- tentiates the bronchodilator response, synergy with the basal release of EpDRF has to be assumed until proper bioassay/ biochemical data demonstrate activated release. The original bioassay experiments suggesting the existence of a diffusible factor responsible for the inhibitory effect of the epithelium seemed convincing, at least to the passionate believer (116) . To be honest, one is not overwhelmed by the number of further studies providing more refined bioassay data demonstrating the existence of EpDRF beyond doubt, as has been demonstrated for endothelium-derived vasoactive factors (78) . Experiments using blood vessels as bioassay effectors are interesting (34, 61, 108). However, they may be less relevant for bronchial reactivity and, rather, illustrate the ability of the airway epithelium to reduce pulmonary vascular tone. This ability is lost in hypoxia (4, 5, 27), suggesting that epithelial cells may play a determinant role in hypoxic pulmonary vasoconstriction and, thus, contribute to the adjustments of the ventilation-perfusion ratio in the lung. Similarly, the simultaneous measurement of mechanical responses and transepithelial potential difference and resistance is an ingenious tour de force (68, 69), but we have learned the hard way in the blood vessel wall that endothelium-dependent changes in membrane potential do not necessarily demonstrate the existence of a diffusible mediator (32). If diffusible mediators contribute to epithelium-dependent relaxations of airway smooth muscle, it appears that, as in the blood vessel wall (32, 78), a single substance cannot be held responsible and that multiple cell types most likely are involved.
What Could EpDRF Be?
Metabolites of arachidonic acid. The earlier suggestions (84) that prostaglandin E 2 can contribute to epithelium-dependent responses have been confirmed (14, 19, 50, 53, 58) and reemphasized (18, 43, 45, 100). In other tubular structures of the body, prostaglandin E 2 also appears to play a key role in epithelium-dependent control of smooth muscle tone (100). In airways, cyclooxygenase (COX)-2 may well be the key source of the prostanoid. For example, the epithelium-dependent relaxation of the guinea pig trachea to bradykinin is accompanied by an augmented generation by COX-2 of prostaglandin E 2 , which in turn activates inhibitory EP 3 receptors of the airway smooth muscle cells (105) . Similarly, in airways from caveolin-1 knockout mice, the epithelium-dependent attenuation of the response to metacholine is also mediated by COX-2 (107). Other products of the metabolism of arachidonic acid, in particular epoxyeicosatrienoic acids, also may contribute to epithelium-dependent hyperpolarizations and relaxations (3, 6, 23, 84, 106) .
Gaseous transmitters. Airways contain the three isoforms of NO synthase (NOS), and the production of endogenous NO confers bronchoprotection and certainly modulates airway tone (12, 20, 33, 43-45, 52, 91, 123) . However, the role of NO as an EpDRF is far from clear. Several early pharmacological studies did not support the involvement of NO and/or the production of cGMP in the epithelium-dependent modulation of airway tone (84, 89) . By contrast, more recently, it has been proposed that NO contributes to several epithelium-dependent responses of airways (Table 3) . However, the origin (and action) of NO is not obvious. Thus epithelium-dependent relaxations of the guinea pig airways to bradykinin are reduced by endothelial and neuronal NOS inhibitors (89, 105) . In human bronchi, if NO contributes to the epithelium-dependent inhibitory effect of brain natriuretic peptide, it is produced in subepithelial cell layers, rather than in the epithelium, and inducible NOS may be its major source (79) . Another gaseous transmitter, CO, also has been implicated in certain epitheliumdependent responses (30). The fashionable H 2 S does not seem to have appeared on the EpDRF scene.
Neurotransmitters. The airway epithelium contains all the essential components of the nonneuronal cholinergic system, and the acetylcholine that it generates presumably exerts local autocrine and paracrine effects (45, 71, 76, 93, 97, 98) (65) . In human bronchi, the epithelium-dependent inhibitory effect of brain natriuretic peptide has been attributed to the release of acetylcholine by the epithelium; the cholinergic agonist, in turn, activates M 2 muscarinic receptors in subepithelial cells coupled to the increased production (mainly by inducible NOS) of NO, which decreases the responsiveness of the bronchial smooth muscle (79) . Thus the possibility that acetylcholine acts as a first epithelium-derived messenger initiating secondary epithelium-dependent relaxations should be considered. Similarly, airway epithelial cells can produce GABA, which Cytokines. Epithelial cells can generate a number of cytokines and participate in inflammatory responses (16, 62, 63, 73, 90, 96) . The release of inflammatory mediators in airway epithelial cells is stimulated by ␤ 2 -adrenoceptor agonists (64) . Although released cytokines are not likely to cause acute changes in airway responsiveness, they could do so indirectly by inducing enzymes that generate bronchoactive substances, in particular inducible NOS (79) and COX-2 (105, 107) .
The above summary of putative mediators leaves one with the uneasy feeling that epithelium dependency of airway responsiveness is a rather mixed bag (or, in the author's mother tongue, "Quelle salade!"). In the blood vessel wall also, several endothelium-derived substances or electrophysiological signals can modulate the tone of the underlying vascular smooth muscle (32, 78). However, the situation is much less confusing than in the airways, as in most cases the endothelium forms a rather homogenous monolayer separated from the vascular smooth muscle only by a basal membrane, allowing cell-to-cell contacts through myoendothelial couplings. By contrast, the surface epithelium of airways is composed of polarized cells with very different phenotypes (basal, ciliated, brush, goblet, secretory, neuroendocrine, and Clara cells; Fig. 2) ; the distribution of these phenotypes varies with the size of the airways, and their individual function in terms of epithelium-dependent responses is unclear, to say the least (17, 66, 67, 70 -72, 77, 95). In addition, certainly in the trachea and the large bronchi, the surface epithelium is separated from the airway smooth muscle by subepithelial layers [in our early work, we had selected to ignore them, although we very well knew that they were present ( Fig. 1)] , which contain fibroblasts, mast cells, nerve endings, and blood vessels. Hence, one must reconsider the simple-minded idea of an EpDRF generated by the epithelium and crossing these subepithelial structures to directly inhibit the contractile process in the airway smooth muscle. It seems much more logical to assume that epithelium dependency is due to a cellular cascade, with individual epithelial cells secreting the initial signal [e.g., acetylcholine (71, 79) ] for the subepithelial partners, which, in turn, possibly with a further relay(s), generate the mediator ultimately inhibiting the airway smooth muscle cells (Fig. 3) . This certainly would explain the intricacy of the involvement of the different isoforms of NOS and COX in epithelium-dependent responses (13, 80, 105).
What Is Next?
The immediate challenge to achieve a better understanding of the mechanism(s) underlying the epithelium dependency of airway responsiveness is to define the role played by the individual epithelial and subepithelial cells. For the former, we may have to keep in mind that, under normal circumstances, they are tightly bound and polarized (62) and, thus, that their secretion toward the lumen may not be relevant to the control of the deeper layers of the airways. One would, rather, want to bioassay/measure what is released at the immediate interface between the subepithelial layer and the smooth muscle cells, which is easy to say but difficult to do! Using proteomic and metabolomic approaches, we would need to better understand how each phenotype (e.g. ciliated, basal, or goblet cells) is compatible with the secretion of messenger molecules toward the subepithelial layers. Mixed cultures between epithelial and subepithelial cell types and between subepithelial cell types and airway smooth muscle, rather than between epithelial and smooth muscle cells, would certainly considerably clarify our understanding.
Conclusion
When revisiting after nearly a quarter of a century the role of the epithelium in the control of airway smooth muscle tone, one is first left with a feeling of confusion, rather than the increased clarity that one had anticipated. The only sound and easy conclusion is that, yes, the presence of a healthy epithelium can moderate the contraction of the underlying airway smooth muscle. It does so not only by acting as a barrier/sink for bronchoconstrictor substances, but also by generating inhibitory messages, whether diffusible substances, electrophysiological signals, or both. The epithelium-dependent inhibitory effect can be tonic (basal), synergistic, or evoked. However, the original hypothesis of a unique EpDRF is no longer tenable; rather, it appears that several known endogenous bronchoactive mediators contribute, and among them, NO and prostaglandin E 2 remain the usual interacting major suspects. This obviously may relate to the fact that, unlike the vascular endothelium, the airway epithelium contains more than one cell type. In retrospect, the early concept of an EpDRF generated by the epithelial cells and diffusing all the way through the subepithelial layers to directly relax the airway smooth muscle appears naive. A much more likely scenario is that, tonically or upon activation, the epithelial cells release true messenger molecules (acetylcholine, GABA, and cytokines), which in turn alter the production of endogenous substances (NO and/or metabolites of arachidonic acid) by the subepithelial layers. These substances then diffuse to the airway smooth muscle cells, indirectly conveying epithelium dependency to their responses.
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